Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Sarcoma, Ewing × Ifosfamide × Clear all

Phase

Phase 2 3 Phase 3 2 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 7 Lymphoma, Large B-Cell, Diffuse 5 Osteosarcoma 4 Lymphoma 4 Wilms Tumor 3 Neuroectodermal Tumors, Primitive, Peripheral 3 Neoplasms 3 Carcinoma, Renal Cell 3 Retinoblastoma 2 Optic Nerve Glioma 2 Neuroblastoma 2 Melanoma 2 Medulloblastoma 2 Lymphoma, Non-Hodgkin 2 Hodgkin Disease 2 Carcinoma, Hepatocellular 2 Astrocytoma 2 Waldenstrom Macroglobulinemia 1 Uveal Melanoma 1 Unspecified Adult Solid Tumor, Protocol Specific 1 Thrombocytopenia 1 Testicular Neoplasms 1 Stomach Neoplasms 1 Solid Tumors 1 Sarcoma, Synovial 1 Sarcoma, Ewing 1 Sarcoma, Alveolar Soft Part 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Rectal Neoplasms 1

Interventions

Cyclophosphamide 6 Topotecan 5 Melphalan 5 Busulfan 5 Temozolomide 4 Irinotecan 4 Granulocyte Colony-Stimulating Factor 4 Filgrastim 4 liposomal doxorubicin 3 fludarabine phosphate 3 fludarabine 3 cabozantinib 3 regorafenib 2 pegfilgrastim 2 Vincristine 2 Sirolimus 2 Bone Marrow Transplantation 2 trioctyl phosphine oxide 1 thymoglobulin 1 talazoparib 1 selinexor 1 seclidemstat 1 racotumomab 1 poly ICLC 1 pembrolizumab 1 pegylated granulocyte colony-stimulating factor 1 olaparib 1 niraparib 1 lexatumumab 1 ixazomib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07194044 2026-03-16

METTSEO

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Recruiting

Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon ⚡